Sinae Bromhexine Hydrochloride fabrica, supplementum, Factory

Quiescere potes ex officina nostra emere Bromhexine Hydrochloride in Sinis. Pharmaceutical Run'an professionalis Sinarum Bromhexine Hydrochloride fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.

Hot Products

  • CAS NO.1122-28-7

    CAS NO.1122-28-7

    Formulae hypotheticae: C5H2N4
    Pondus hypotheticum: 118.1
    CAS NO.1122-28-7 est Synthesis Oligonucleotide, media.
  • CAS 2050-87-5

    CAS 2050-87-5

    CAS 2050-87-5 est resistentiae Antimicrobiae et medicamentis anti-inflammatoriis.
  • Gemcitabine HCl API

    Gemcitabine HCl API

    Seres productum nomen: Gemcitabine HCl
    Sinensis alias: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl] -1h-pyrimidin-2-one hydrochloride; Anti-tumor Gemcitabine
    Anglicus productum nomen: Gemcitabinum hydrochloridum
    CAS#122111-03-9
  • CAS NO.122111-03-9

    CAS NO.122111-03-9

    Seres productum nomen: Gemcitabine HCl
    Sinensis alias: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl] -1h-pyrimidin-2-one hydrochloride; Anti-tumor Gemcitabine
    Anglicus productum nomen: Gemcitabinum hydrochloridum
    CAS NO.122111-03-9
  • Cas no.123663-49-0

    Cas no.123663-49-0

    Seres Product Name: Ellamod
    Seres alias: N [3 (Carboxamido) -4-Oxo-VI-phenoxy-4h-I-Benzopyran-VII-YL] Methanesulfonamide
    Latina Product Name: iguratimod
    Cas no.123663-49-0
    Molecular formula: c17h14n2o6s
    Molecular pondus: 374,3679
    Specie et proprietates alba pulveris
    Domesticis Registration Number API: Y20190021542
  • 288-94-8

    288-94-8

    Formulae hypotheticae: CH2N4
    Pondus hypotheticum: 70.05
    288-94-8, coloris crystallini in levi flavo olet.

Mitte Inquisitionem

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept